수술 계획용 증강현실(AR) 시장 : 전략적 인사이트 및 예측(2026-2031년)

The Augmented Reality for Surgery Planning Market is expected to grow at a 12.99% CAGR, increasing from USD 845.079 million in 2025 to USD 1758.321 million in 2031.

The augmented reality for surgery planning market is undergoing significant transformation driven by the paradigm shift toward precision surgery, the growing complexity of image-guided procedures, and the increasing integration of digital visualization tools into surgical workflows. The market's evolution is characterized by the recognition that AR systems allow surgeons to interact with three-dimensional anatomical models derived from CT and MRI datasets, improving spatial understanding before surgery and reducing cognitive burden during complex interventions. The convergence of advanced visualization hardware, registration technology, and surgical navigation platforms is enabling more intuitive, accurate, and efficient surgical planning. FDA-cleared platforms from companies such as Augmedics and integrations involving Medtronic and Surgical Theater demonstrate that AR has progressed beyond experimental visualization into regulated clinical applications. Adoption remains concentrated in specialties where anatomical precision carries substantial clinical and economic consequences, particularly neurosurgery, orthopedic surgery, and spine procedures. The market is witnessing significant investment in software capabilities, navigation integration, and clinical evidence generation, positioning AR for surgery planning as a critical component of modern digital surgery ecosystems.

Market Drivers

• The growing procedural complexity in image-guided surgery represents the primary driver for the AR for surgery planning market. Neurosurgical, spinal, and reconstructive procedures increasingly depend on accurate interpretation of patient-specific anatomy. Higher imaging volumes and more complex interventions have increased demand for visualization tools that reduce cognitive burden during planning. AR systems allow surgeons to interact with three-dimensional anatomical models derived from CT and MRI datasets, improving spatial understanding before surgery. Clinical deployments by Augmedics and Surgical Theater illustrate how suppliers are positioning AR as a practical extension of navigation workflows rather than a standalone visualization technology, resulting in sustained growth in AR surgery planning utilization. The expansion of image-guided surgical navigation platforms is further accelerating market growth through integration of AR capabilities. Hospitals are already investing heavily in navigation technologies for spine, cranial, ENT, and orthopedic procedures. AR vendors increasingly integrate their software into existing navigation ecosystems rather than replacing them. Medtronic's partnerships and navigation platform development demonstrate how AR capabilities are being incorporated into broader surgical guidance systems, lowering adoption barriers for healthcare providers. Regulatory progress supporting clinical adoption is expanding the addressable market by validating safety and clinical performance requirements. FDA clearances for AR-based surgical guidance platforms have expanded the addressable market by validating safety and clinical performance requirements. Pressure to improve operating room efficiency is attracting attention from hospital administrators seeking technologies that reduce workflow interruptions and improve surgical confidence. Advances in visualization hardware and registration technology are improving the economic viability of AR deployment across a broader range of hospitals.

Market Restraints

• High integration requirements within surgical workflows frequently extend implementation timelines and increase deployment costs. Successful deployment requires compatibility with imaging systems, navigation platforms, hospital IT infrastructure, and surgical instruments. Limited long-term clinical evidence across multiple specialties creates a slower adoption cycle for vendors seeking expansion beyond established use cases. Procurement committees frequently require specialty-specific outcome data before approving technology purchases. Capital expenditure constraints in healthcare systems require providers to demonstrate measurable improvements before approving large-scale deployments. Surgeon training and adoption barriers can delay implementation, particularly in facilities with limited experience in advanced image-guided surgery. Accuracy and registration requirements can reduce clinical confidence and restrict use in high-risk procedures if alignment between virtual anatomical models and physical anatomy is not precise.

Technology and Segment Insights

• The technology landscape is characterized by the growing importance of software capabilities, navigation integration, and ergonomic hardware design. Neurosurgery represents the most strategically important segment because procedures frequently involve complex anatomy, limited surgical access, and high clinical consequences associated with navigation errors. Surgical teams routinely analyze extensive MRI and CT datasets before intervention, creating a natural environment for immersive three-dimensional planning tools. Demand is supported by the need for improved visualization of tumors, vascular structures, neural pathways, and critical functional regions. AR systems allow surgeons to rehearse approaches, evaluate trajectories, and overlay anatomical information during planning and navigation. Medtronic's collaboration with Surgical Theater and expanding AR-enabled cranial navigation capabilities demonstrate continued investment in this specialty. Purchasing decisions in neurosurgery differ from those in many other specialties. Buyers place greater emphasis on accuracy, image fidelity, workflow integration, and compatibility with navigation systems than on hardware specifications alone. Hospitals also require robust clinical validation because neurosurgical procedures carry substantial patient safety implications. As a result, suppliers compete through software capabilities, navigation integration, and evidence generation rather than display hardware alone. The segment analysis reveals that competition is increasingly centered on ecosystem integration rather than standalone hardware performance. North America remains the most mature commercial environment, with the United States generating much of the clinical evidence, regulatory activity, and commercialization activity associated with AR surgical navigation. European adoption is driven primarily by university hospitals, research collaborations, and advanced surgical centers. Asia Pacific presents long-term growth potential because of expanding healthcare infrastructure, increasing surgical volumes, and rising investment in digital operating room technologies. The integration of navigation platforms is becoming increasingly important as AR vendors integrate their software into existing navigation ecosystems rather than replacing them.

Competitive and Strategic Outlook

• The competitive landscape remains technology-led and increasingly centered on integration within surgical navigation ecosystems, including established medical technology companies alongside specialized AR developers. Medtronic leverages its installed base of navigation and imaging systems, enabling AR functionality to be incorporated into existing surgical workflows, with partnerships and platform strategy strengthening switching costs and creating opportunities for broader adoption across multiple specialties. Augmedics has focused on dedicated AR navigation systems, particularly within spine surgery, with commercial progress, clinical utilization, and continued product development highlighting the role of specialist vendors in advancing AR adoption. Philips Healthcare benefits from its presence in imaging and image-guided therapy infrastructure, while Intuitive Surgical contributes expertise in digital surgical workflows and visualization environments. Companies such as Surgical Theater, EchoPixel, Scopis GmbH, Vuzix Corporation, AccuVein, and VirtaMed AG address specific visualization, simulation, guidance, and hardware requirements, with competitive positioning often depending on workflow specialization, imaging compatibility, and clinical validation. Barriers to entry remain substantial, with regulatory approval requirements, clinical evidence generation, surgeon adoption cycles, and integration demands creating challenges for new entrants lacking established healthcare relationships. Recent key developments include SKIA securing FDA 510(k) clearance for its SKIA HEAD platform, a tablet-based augmented reality system that projects patient-specific 3D anatomy onto the body. Pixee Medical received FDA clearance for Knee+ NexSight, a next-generation augmented reality solution for total knee arthroplasty. VB Spine agreed to acquire Augmedics' xvision Spine System, adding FDA-cleared augmented reality navigation capabilities for real-time anatomical visualization and planning support. OnPoint AI highlighted its OnPoint AR Spine System, which overlays virtual surgical guides and implants directly into the surgeon's field of view. Medivis received FDA clearance for its Cranial Navigation platform, becoming the first augmented reality system authorized for intraoperative cranial neurosurgery guidance.

Short Conclusion

• The augmented reality for surgery planning market is positioned for sustained growth driven by the convergence of procedural complexity, navigation platform integration, and technological advancement. The transition from experimental visualization toward integrated surgical planning ecosystems represents a fundamental shift in digital surgery. While challenges related to workflow integration, clinical evidence, and adoption barriers persist, strategic investments in software capabilities, navigation integration, and regulatory clearance are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with AR for surgery planning evolving into a critical component of modern digital surgery, supporting improved planning accuracy, workflow efficiency, and clinical outcomes across neurosurgery, orthopedics, and emerging surgical specialties.

Key Benefits of this Report

• Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

• Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation, and trade analysis
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY SURGICAL SPECIALTY

• 5.1. Introduction
• 5.2. Orthopedic Surgery
• 5.3. Neurosurgery
• 5.4. Cardiovascular Surgery
• 5.5. Plastic And Reconstructive Surgery
• 5.6. Gastrointestinal Surgery
• 5.7. Others

6. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY COMPONENT

• 6.1. Introduction
• 6.2. Hardware (AR Glasses, Displays, Cameras)
• 6.3. Software (Surgical Planning Software, Ar Apps)
• 6.4. Services (Consulting, Support, Training)

7. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Preoperative Planning
• 7.3. Intraoperative Navigation
• 7.4. Training And Education
• 7.5. Surgical Visualization

8. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals And Clinics
• 8.3. Ambulatory Surgery Centers
• 8.4. Research Institutions
• 8.5. Medical Schools
• 8.6. Others

9. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Medtronic Plc
• 11.2. Accuvein Inc.
• 11.3. Echopixel, Inc.
• 11.4. Philips Healthcare
• 11.5. Scopis Gmbh
• 11.6. Augmedics
• 11.7. Surgical Theater LLC
• 11.8. Intuitive Surgical, Inc.
• 11.9. Virtamed Ag
• 11.10. Vuzix Corporation

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations